Martínez-Sobrido Luis, Emonet Sébastien, Giannakas Panagiotis, Cubitt Beatrice, García-Sastre Adolfo, de la Torre Juan C
Department of Immunology, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, New York 10029, USA.
J Virol. 2009 Nov;83(21):11330-40. doi: 10.1128/JVI.00763-09. Epub 2009 Aug 26.
Lymphocytic choriomeningitis virus (LCVM) nucleoprotein (NP) counteracts the host type I interferon (IFN) response by inhibiting activation of the IFN regulatory factor 3 (IRF3). In this study, we have mapped the regions and specific amino acid residues within NP involved in its anti-IFN activity. We identified a region spanning residues 382 to 386 as playing a critical role in the IFN-counteracting activity of NP. Alanine substitutions at several positions within this region resulted in NP mutants that lacked the IFN-counteracting activity but retained their functions in virus RNA synthesis and assembly of infectious particles. We used reverse genetics to rescue a recombinant LCMV strain carrying mutation D382A in its NP [rLCMV/NP*(D382A)]. Compared to wild-type (WT) LCMV, rLCMV/NP*(D382A) exhibited a higher level of attenuation in IFN-competent than IFN-deficient cells. In addition, A549 cells infected with rLCMV/NP*(D382A), but not with WT LCMV, produced IFN and failed to rescue replication of the IFN-sensitive Newcastle disease virus.
淋巴细胞性脉络丛脑膜炎病毒(LCVM)核蛋白(NP)通过抑制干扰素调节因子3(IRF3)的激活来对抗宿主I型干扰素(IFN)反应。在本研究中,我们绘制了NP中参与其抗IFN活性的区域和特定氨基酸残基。我们确定了一个跨越382至386位残基的区域在NP的IFN对抗活性中起关键作用。该区域内几个位置的丙氨酸替代产生了NP突变体,这些突变体缺乏IFN对抗活性,但保留了它们在病毒RNA合成和感染性颗粒组装中的功能。我们使用反向遗传学拯救了一种在其NP中携带突变D382A的重组LCMV株[rLCMV/NP*(D382A)]。与野生型(WT)LCMV相比,rLCMV/NP*(D382A)在有IFN能力的细胞中比在IFN缺陷细胞中表现出更高水平的减毒。此外,感染rLCMV/NP*(D382A)而非WT LCMV的A549细胞产生了IFN,并且未能拯救IFN敏感的新城疫病毒的复制。